Ridgefield resident Katherine Quesenberry, DVM, MPH, DABVP (Avian), has been named chief medical officer at New York City’s Animal Medical Center, the world’s largest non-profit veterinary hospital, an announcement about the appointment said.
Dr. Quesenberry, who most recently served as the head of the Avian and Exotic Pet Services at AMC, brings more than three decades of experience in animal care, research, and veterinary leadership to the role.
In her new capacity, Dr. Quesenberry will be responsible for providing medical oversight and direction of all clinical activities to AMC’s 100 veterinarians.
As AMC approaches its 110-year milestone and manages a record caseload of more than 54,000 patient visits each year, Dr. Quesenberry will ensure the institution’s continued legacy as a leader in veterinary medicine. She is charged with maintaining the highest standards in patient care, research, and education.
Over the course of her tenure at AMC, Dr. Quesenberry led AMC’s Avian and Exotic Pet Service, during which time she trained over 20 residents and specialty interns in the veterinary care of exotic pets. She has authored numerous scientific articles and has lectured widely both nationally and internationally on topics in this veterinary specialty.
Dr. Quesenberry is a member of the Editorial Board of the Merck Veterinary Manual and has served as the scientific editor of the Journal of Avian Medicine and Surgery for the Association of Avian Veterinarians, since 1994. She is co-editor of Ferrets, Rabbits and Rodents: Clinical Medicine and Surgery, published by Elsevier, which is a best seller in veterinary medicine and is now going into its fourth edition. She was a co-editor of Avian Medicine and Surgery, also published by Elsevier. In 2017, Dr. Quesenberry was presented with the prestigious Oxbow Exotic Mammal Health Award in recognition of her contributions to the field of exotic mammal medicine and care.
“Katherine Quesenberry is a world-class veterinary professional with extraordinary leadership skills, clinical expertise and strong research credentials, along with a true passion for veterinary medicine,” said Kathryn Coyne, chief executive officer at AMC. “Dr. Quesenberry’s 35-plus-year legacy at AMC is marked by countless contributions to the advancement and evolution of veterinary medicine, and we are fortunate to have such a highly qualified individual to provide superior medical leadership.”
“To me, AMC is unique in the field of veterinary medicine, symbolizing the best of what our profession can offer to both the veterinary community and to the public at large,” said Dr. Quesenberry. “In my new role as chief medical officer, I look forward to working with our extraordinary veterinary staff to ensure that AMC continues to be the premier provider of care, clinical research on naturally-occurring diseases, and education in the veterinary field.”